4167 studies found for:    Arteriosclerosis
Show Display Options
Rank Status Study
21 Completed Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
Conditions: Coronary Disease;   Arteriosclerosis;   Diabetes Mellitus, Type 2
Interventions: Drug: Aspirin;   Drug: No aspirin
22 Completed An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).
Conditions: Cardiovascular Diseases;   Vascular Disease;   Arterial Occlusive Disease;   Arteriosclerosis;   Atherosclerosis
Intervention: Device: Cypher Stent
23 Completed Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke
Conditions: Ischemic Stroke;   Myocardial Ischemia;   Coronary Arteriosclerosis
24 Terminated Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant (Auditor)
Conditions: Carotid Artery Plaque;   Arteriosclerosis;   Obesity;   Metabolic Syndrome X
Interventions: Drug: rimonabant (SR141716);   Drug: placebo
25 Completed Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
Conditions: Type 2 Diabetes Mellitus;   Arteriosclerosis Obliterans
Interventions: Drug: Cilostazol;   Drug: Probucol;   Drug: Cilostazol+Probucol;   Other: Control Group
26 Completed
Has Results
Identifying the Anti-Blood-Clotting Compounds in Garlic
Conditions: Arteriosclerosis;   Intracranial Arteriosclerosis
Interventions: Dietary Supplement: garlic powder added to ambient water;   Dietary Supplement: garlic powder added to boiling water
27 Completed The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions
Conditions: Coronary Artery Disease;   Arterial Occlusive Diseases;   Coronary Disease;   Coronary Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Ischemia;   Arteriosclerosis
Intervention: Device: Endeavor drug eluting coronary stent
28 Completed
Has Results
Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device
Conditions: Angioplasty, Transluminal, Percutaneous Coronary;   Coronary Arteriosclerosis;   Peripheral Arteriosclerosis
Interventions: Other: Manual Compression;   Device: Vascular Closure Device
29 Recruiting Effects of Anesthetics on Postoperative Cognitive Function of Patients Undergoing Endovascular Repair of Aortic Aneurysm and Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities.
Conditions: Endovascular Repair of Aortic Aneurysm;   Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities
Interventions: Drug: Sevoflurane;   Drug: Propofol;   Drug: Remifentanil
30 Terminated Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)
Conditions: Arteriosclerosis;   Hypertension;   Heart Diseases
31 Active, not recruiting Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
Condition: Atherosclerosis
32 Completed Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
Condition: Atherosclerosis Cerebral Infarction
Interventions: Drug: Cilostazol group;   Drug: Probucol group;   Drug: Cilostazol + Probucol group;   Drug: control group
33 Completed Familial Atherosclerosis Treatment Study
Conditions: Cardiovascular Diseases;   Coronary Arteriosclerosis;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Drug: lovastatin;   Drug: colestipol;   Drug: niacin
34 Recruiting Acoustic Radiation Force Impulse (ARFI) Ultrasound for Noninvasive, Diagnostic Atherosclerosis Imaging
Condition: Atherosclerosis
35 Completed Imaging of Atherosclerosis With 68Ga-MSA
Conditions: Atherosclerosis;   Noninvasive Imaging of Atherosclerosis
36 Completed Reducing Total Cardiovascular Risk in an Urban Community
Conditions: Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Diabetes Mellitus;   Atherosclerosis;   Cerebral Arteriosclerosis;   Hypertension
Interventions: Behavioral: Lifestyle Changes;   Drug: Antiplatelet Agents;   Drug: Beta Blocker;   Drug: ACE Inhibitors
37 Completed BIOLUX P-I First in Man Study
Conditions: Atherosclerosis;   Arteriosclerosis;   Vascular Disease;   Peripheral Artery Disease
Interventions: Device: Passeo-18 Lux DRB;   Device: Standard PTA (POBA)
38 Completed LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropoliteal Restenosis
Conditions: Atherosclerosis;   Vascular Disease;   Arteriosclerosis
Interventions: Device: Lutonix Catheter;   Device: Standard uncoated Balloon Angioplasty Catheter
39 Active, not recruiting BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries
Conditions: Atherosclerosis;   Arteriosclerosis;   Vascular Disease;   Peripheral Artery Disease
Interventions: Device: Passeo-18 Lux DRB;   Device: Standard PTA (POBA)
40 Completed The Copenhagen Insulin and Metformin Therapy Trial
Conditions: Type 2 Diabetes;   Atherosclerosis;   Arteriosclerosis
Interventions: Drug: metformin;   Drug: insulin detemir;   Drug: insulin aspart + insulin aspart protamin;   Drug: Insulin aspart

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years